Ambea AB (CHIX:AMBEAS) Peter Lynch Fair Value: kr155.84 (As of Jul. 13, 2026) — 21544% Above Median


CHIX:AMBEAS Ambea AB CHIX:AMBEAS
83 GF Score
Price kr144.20
GF Value kr110.51
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ambea AB Peter Lynch Fair Value?

Ambea AB CHIX:AMBEAS 83 Peter Lynch Fair Value is kr155.84 as of Jul. 13, 2026, which is 100% below its 10-year median of 0.72. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr110.51 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 170 Healthcare Providers & Services companies, Ambea AB ranks better than 63.53% on this metric.

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Ambea AB's PEG is 1. Ambea AB's 5-Year TTM EBITDA Growth Rate is 18.27. Ambea AB's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was kr8.53. Therefore, the Peter Lynch Fair Value for today is kr155.84.

As of today (2026-07-13), Ambea AB's share price is kr144.20. Ambea AB's Peter Lynch fair value is kr155.84. Therefore, Ambea AB's Price to Peter Lynch Fair Value Ratio for today is 0.93.


The historical rank and industry rank for Ambea AB's Peter Lynch Fair Value or its related term are showing as below:

CHIX:AMBEAs' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.37   Med: 0.72   Max: 1.01
Current: 0.92


During the past 12 years, the highest Price to Peter Lynch Fair Value Ratio of Ambea AB was 1.01. The lowest was 0.37. And the median was 0.72.


CHIX:AMBEAs's Price-to-Peter-Lynch-Fair-Value is ranked better than
63.53% of 170 companies
in the Healthcare Providers & Services industry
Industry Median: 1.19 vs CHIX:AMBEAs: 0.92

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Ambea AB  (CHIX:AMBEAs) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 18.27 instead of 15 in this case.

Ambea AB's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=144.20/155.84
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambea AB Peter Lynch Fair Value Related Terms


Ambea AB Peter Lynch Fair Value Historical Data

* Premium members only.

The historical data trend for Ambea AB's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB Peter Lynch Fair Value Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.65 96.48 87.53 99.01 125.21

Ambea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.54 121.60 141.54 125.21 143.50

CHIX:AMBEAS vs HCA, THC, DVA: Peter Lynch Fair Value Comparison

For the Medical Care Facilities subindustry, Ambea AB's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambea AB Price-to-Peter-Lynch-Fair-Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Ambea AB's Price-to-Peter-Lynch-Fair-Value falls into.


CHIX:AMBEAS
83GF Score
Ambea AB CHIX:AMBEAS
Peter Lynch Fair Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambea AB Peter Lynch Fair Value Calculation

Ambea AB's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 18.27 *8.53
=155.84

Ambea AB's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8.53.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.

Frequently Asked Questions Learn more about Peter Lynch Fair Value →
What does a Peter Lynch Fair Value of kr155.84 mean?
Ambea AB (CHIX:AMBEAS) has a Peter Lynch Fair Value of kr155.84 as of Jul. 13, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Ambea AB and its competitors. This is 21544% above median its historical median of 0.72. Over the past decade, Ambea AB's Peter Lynch Fair Value has ranged from 0.37 to 1.01. According to the industry distribution chart, Ambea AB ranks #62 out of 170 companies in the Healthcare Providers & Services industry, placing it in the top 36.5%.
Is Ambea AB's Peter Lynch Fair Value too high?
Ambea AB's current Peter Lynch Fair Value of kr155.84 is 21544% above median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 1.01. Based on the distribution chart, Ambea AB ranks #62 out of 170 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Peter Lynch Fair Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #62 out of 170 companies for Peter Lynch Fair Value. This puts Ambea AB in the upper half of its industry. The industry median Peter Lynch Fair Value is 1.19. Historically, Ambea AB's own Peter Lynch Fair Value has ranged from 0.37 to 1.01 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Healthcare Providers & Services company?
The median Peter Lynch Fair Value among Healthcare Providers & Services companies is 1.19, based on 170 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median Peter Lynch Fair Value is 1.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current Peter Lynch Fair Value is kr155.84, which is 21544% above median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr110.51, compared to a current price of kr144.20 — trading 30.5% above its estimated fair value. The current Peter Lynch Fair Value is kr155.84, which is 21544% above median its 10-year median of 0.72. Ambea AB's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Peter Lynch Fair Value is kr155.84 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of kr144.20 is trading 30.5% above its estimated GF Value™ of kr110.51. GuruFocus considers Ambea AB to be Modestly Overvalued.

Key valuation signals for CHIX:AMBEAS:

  • Peter Lynch Fair Value: kr155.84 (21544% above median its 10-year median of 0.72)
  • GF Value™: kr110.51 vs. price of kr144.20 (30.5% above fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score

Get the complete analysis for CHIX:AMBEAS

Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr144.20
Price
kr110.51
GF Value